Sai Life Sciences to increase headcount by 20 percent as global drug demand surges
The Indian drugmaker plans to add over 700 staff next year to meet rising demand. This expansion comes as global firms shift high-value work to India.
Sai Life Sciences has announced plans to increase its workforce by more than 700 employees, representing an expansion of approximately 20 percent, during the next financial year. This move is designed to scale up capacity in response to rising global demand. The new positions will be concentrated in India 
IN at the Hyderabad R&D centre and manufacturing sites, focusing on drug development, data-enabled drug discovery, and commercial manufacturing scale-up.
IN at the Hyderabad R&D centre and manufacturing sites, focusing on drug development, data-enabled drug discovery, and commercial manufacturing scale-up.
